Daniel Garnet, MD

CIO 2023-9 Bowel Complication following Combined (TACE+Y90) Liver Directed Therapy

Purpose: Primary liver cancer is the sixth most diagnosed cancer and Hepatocellular carcinoma (HCC) accounts for 75-95% of all primary liver cancer cases1. Several studies have been perfo...

Daniel Garnet , MD;

Sami Haddad , MD;

11/01/2023

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

March 27 ⁠–⁠ March 30

See Full Calendar

Daniel Garnet, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products